North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
Titel:
North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
Auteur:
Perez, E.A. Hillman, D.W. Dentchev, T. Le-Lindqwister, N.A. Geeraerts, L.H. Fitch, T.R. Liu, H. Graham, D.L. Kahanic, S.P. Gross, H.M. Patel, T.A. Palmieri, F.M. Dueck, A.C.